Works matching DE "PURDUE Pharma LP"
Results: 39
OxyContin, prescription opioid abuse and economic medicalization.
- Published in:
- Medicolegal & Bioethics, 2012, v. 2, p. 31, doi. 10.2147/MB.S32040
- By:
- Publication type:
- Article
Big Pharma and Physician Education.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
Buprenorphine transdermal system has REMS.
- Published in:
- American Journal of Health-System Pharmacy, 2010, v. 67, n. 16, p. 1306, doi. 10.2146/news100055
- By:
- Publication type:
- Article
Acetaminophen's maximum dosage yields unexpected result.
- Published in:
- American Journal of Health-System Pharmacy, 2006, v. 63, n. 17, p. 1581, doi. 10.2146/news060006
- By:
- Publication type:
- Article
FDA embraces RFID to protect drug supply.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 24, p. 2612, doi. 10.1093/ajhp/61.24.2612
- By:
- Publication type:
- Article
THE WEATHERVANE.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
OPIOID LAWSUITS: IS THERE ANY END IN SIGHT?
- Published in:
- Health Matrix: Journal of Law-Medicine, 2023, v. 33, p. 193
- By:
- Publication type:
- Article
The Rule of the Deal: Bankruptcy Bargains and Other Misnomers.
- Published in:
- American Bankruptcy Law Journal, 2023, v. 97, n. 1, p. 41
- By:
- Publication type:
- Article
"A Bitter Result": Purdue Pharma, a Sackler Bankruptcy Filing, and Improving Monetary and Nonmonetary Recoveries in Mass Tort Bankruptcies.
- Published in:
- American Bankruptcy Law Journal, 2022, v. 96, n. 2, p. 361
- By:
- Publication type:
- Article
Designing Designer Bankruptcy.
- Published in:
- Texas Law Review, 2024, v. 102, n. 6, p. 1205
- By:
- Publication type:
- Article
"Special": Remedial Schemes in Mass Tort Bankruptcies.
- Published in:
- Texas Law Review, 2023, v. 101, n. 7, p. 1773
- By:
- Publication type:
- Article
Purdue's Poison Pill: The Breakdown of Chapter 11's Checks and Balances.
- Published in:
- Texas Law Review, 2022, v. 100, n. 6, p. 1079
- By:
- Publication type:
- Article
OxyContin and a Regulation Deficiency of the Pharmaceutical Industry: Rethinking State-Corporate Crime.
- Published in:
- Critical Criminology, 2011, v. 19, n. 3, p. 213, doi. 10.1007/s10612-010-9113-9
- By:
- Publication type:
- Article
PURDUE PHARMA AND SHIONOGI TO COLLABORATE ON ANALGESIC RESEARCH AND MARKETING.
- Published in:
- Journal of Pain & Palliative Care Pharmacotherapy, 2006, v. 20, n. 3, p. 111
- Publication type:
- Article
A Trojan Horse Inside the Gates? Knowledge Spillovers During Patent Litigation.
- Published in:
- Academy of Management Journal, 2022, v. 65, n. 5, p. 1747, doi. 10.5465/amj.2018.1181
- By:
- Publication type:
- Article
From the FDA.
- Published in:
- Brown University Child & Adolescent Psychopharmacology Update, 2005, v. 7, n. 8, p. 8
- Publication type:
- Article
Erratum.
- Published in:
- 2010
- Publication type:
- Correction Notice
PRODUCT HOPPING 2.0: GETTING THE FDA TO YANK YOUR ORIGINAL LICENSE BEATS STACKING PATENTS.
- Published in:
- Marquette Intellectual Property Law Review, 2015, v. 19, n. 2, p. 161
- By:
- Publication type:
- Article
Civil Litigation and the Opioid Epidemic: The Role of Courts in a National Health Crisis.
- Published in:
- Journal of Law, Medicine & Ethics, 2018, v. 46, n. 2, p. 351, doi. 10.1177/1073110518782945
- By:
- Publication type:
- Article
The Responsible Corporate Officer, the DeCosters, and the Opioid Epidemic: Why Prison Sentences Based on the RCO Doctrine Do Not Violate Due Process.
- Published in:
- Journal of Corporation Law, 2020, v. 46, n. 2, p. 483
- By:
- Publication type:
- Article
Purdue vEndo: ‘It ain’t over till it’s over’.
- Published in:
- Journal of Generic Medicines, 2006, v. 3, n. 3, p. 226, doi. 10.1057/palgrave.jgm.4940123
- By:
- Publication type:
- Article
Purdue considering naloxone to curb OxyContin abuse.
- Published in:
- Brown University Psychopharmacology Update, 2001, v. 12, n. 11, p. 8
- Publication type:
- Article
Our Opium Wars.
- Published in:
- Third Text, 2018, v. 32, n. 5/6, p. 662, doi. 10.1080/09528822.2018.1559169
- By:
- Publication type:
- Article
Oxycodone cases.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2005, v. 172, n. 11, p. 1432
- Publication type:
- Article
OxyContin class-action suit to proceed.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2003, v. 169, n. 7, p. 699
- Publication type:
- Article
Purdue appeals OxyContin patents.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 2, p. 106, doi. 10.1038/nrd1316
- Publication type:
- Article
Blame or discovery? Walter Benjamin's Jetztzeit, Purdue Pharma LP and 'our values and our historical understanding of psychiatrists'.
- Published in:
- BJPsych Bulletin, 2024, v. 48, n. 2, p. 121, doi. 10.1192/bjb.2023.39
- By:
- Publication type:
- Article
General Release Signed by Qui Tam Relator Does Not Bar Later Suits By Other Relators Alleging the Same Fraud - United States ex rel. May v. Purdue Pharma L.P.
- Published in:
- American Journal of Law & Medicine, 2014, v. 40, n. 1, p. 175, doi. 10.1017/s0098858800000095
- By:
- Publication type:
- Article
Afghanistan and the Purdue Pharma Case are Reminders That the U.S. is a Failed Narco-State, Too.
- Published in:
- CounterPunch, 2021, p. 1
- By:
- Publication type:
- Article
In re Purdue Pharma L. P.: The Second Circuit Justifies the Equitable Authority to Impose Non-Debtor Releases in a Controversial Compromise.
- Published in:
- Tulane Law Review, 2024, v. 98, n. 4, p. 709
- By:
- Publication type:
- Article
Finally, the Sackler Family in the Legal Crosshairs.
- Published in:
- Appalachian Journal, 2018, v. 46, n. 1/2, p. 25
- By:
- Publication type:
- Article
From Absolution to Accountability.
- Published in:
- Boston Review, 2019, v. 44, n. 2, p. 49
- By:
- Publication type:
- Article
How Race Made the Opioid Crisis.
- Published in:
- Boston Review, 2019, v. 44, n. 2, p. 7
- By:
- Publication type:
- Article
Against Bankruptcy Exceptionalism.
- Published in:
- University of Chicago Law Review, 2022, v. 89, n. 8, p. 1925
- By:
- Publication type:
- Article
It's Time to Finish What They Started: How Purdue Pharma and the Sackler Family Can Help End the Opioid Epidemic.
- Published in:
- Penn State Law Review, 2020, v. 125, n. 1, p. 255
- By:
- Publication type:
- Article
PURDUE PHARMA L.P. V. FAULDING INC.
- Published in:
- Berkeley Technology Law Journal, 2002, v. 17, n. 1, p. 95
- By:
- Publication type:
- Article
Debt-Free Bankruptcy: THE PROS AND CONS OF LITIGATING MASS TORT LITIGATION THROUGH BANKRUPTCY.
- Published in:
- Judges' Journal, 2022, v. 61, n. 4, p. 8
- By:
- Publication type:
- Article
BIG TOBACCO'S BIG SETTLEMENT: WHAT PHARMACEUTICAL COMPANIES CAN LEARN TO PROTECT THEMSELVES IN OPIOID LITIGATION.
- Published in:
- University of Louisville Law Review, 2021, v. 60, n. 1, p. 161
- By:
- Publication type:
- Article
Hippocrates and Targin.
- Published in:
- 2016
- By:
- Publication type:
- Letter